Clinical trials: Intrauterine Device (IUD)
Intra-uterine Device Placement
Pain Associated wIth traditioNal Versus uLtrasound guidEd iuS (Intra Uterine System) inSertion
Rationale: The 2019 Belgian Health Survey shows that the combined oral contraceptive pill is the most commonly used form of contraception.
- Trial name
- PAINLESS (NCT07315646)
- Testing
- IUS (intrauterine system) insertion
- Where
- Belgium
- Volunteers
- 50 people
- Sponsor
- University Hospital, Ghent
Intrauterine Devices, Medicated
A Cross-sectional, Observational Multicenter Study to Assess the Reasons for Choosing the 3-year Hormonal IUD and Level of IUDs Knowledge Among Women Aged 18 to 29 Years
A cross-sectional, observational multicenter study to assess the reasons for choosing the 3-year hormonal IUD and level of IUDs knowledge among women aged 18 to 29 years.
- Trial name
- ANALIA (NCT02903888)
- Testing
- Levonorgestrel (Jaydess, Skyla, BAY86-5028)
- Where
- Spain
- Volunteers
- 886 people
- Sponsor
- Bayer
IUD Insertion Pain
the Effect of Isosorbide Mononitrate in Reducing Pain During Cooper Intrauterine Device Insertion
The aim of the study is to evaluate the efficacy of isosorbide mononitrate vaginal administration in reducing pain during copper IUD insertion in nulliparous women
- Trial name
- NCT04312048
- Testing
- Isosorbide mononitrate
- Where
- Egypt
- Volunteers
- 110 people
- Sponsor
- Cairo University
Contraception, Malposition of Intrauterine Contraceptive Device
LNG-IUS at 2 Weeks Postpartum
This is a study of 50 postpartum women interested in having the Mirena® LNG-IUS placed for contraception. The Mirena® is an FDA approved intrauterine contraceptive device that provides contraception for 5 years with excellent…
- Trial name
- LNG-IUS (NCT02121067)
- Testing
- Levonorgestrel Intrauterine System (LNG-IUS)
- Where
- United States
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- University of North Carolina, Chapel Hill
Contraception
Postplacental Intrauterine Device Insertion: A Mixed Methods Assessment of Women's Experience
The primary objective of this mixed methods pilot study is to understand women's experiences with postplacental intrauterine device (IUD) insertion through postpartum semi-structured interviews.
- Trial name
- PIPPI (NCT02312726)
- Testing
- Postplacental IUD insertion
- Where
- United States
- Volunteers
- 135 people, healthy volunteers welcome
- Sponsor
- University of New Mexico
Pain, Anxiety
The Effect of Virtual Reality Application on Pain, Anxiety and Satisfaction of Patients
Today, common and easily accessible android-based smart devices capable of running virtual reality are used. The image is obtained using a combination of framed simple optical lenses that hold the phone at a fixed distance…
- Conditions
- Pain, Anxiety, Satisfaction
- Trial name
- NCT05760040
- Testing
- vırtual reality, Control Group
- Where
- Turkey (Türkiye)
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Marmara University
Pain
Diclofenac Plus Lidocaine Gel for Pain Relief During Intrauterine Device Insertion(IUD).
The aim of this study is to determine the effectiveness of a combination of diclofenac and lidocaine gel in reducing pain during IUD insertion.
- Trial name
- NCT02332057
- Testing
- Diclofenac plus lidocaine
- Where
- Egypt
- Volunteers
- 90 people
- Sponsor
- Cairo University
Intrauterine Device Migration
Post-placental Intrauterine Device Insertion During Cesarean Section
Effective, reversible postpartum contraception decreases the chance of rapid repeat pregnancy and poor perinatal outcome in a subsequent pregnancy especially in women delivered by cesarean section.The traditional 6-week…
- Trial name
- NCT03780985
- Testing
- Intrauterine device insertion, Cesarean section, Suture
- Where
- Egypt
- Volunteers
- 118 people, healthy volunteers welcome
- Sponsor
- Assiut University
Eumenorrhea, Intrauterine Devices, Medicated
Effect of Different Sex Hormone Profiles for the Response to Physical Training
The aim of the project is to elucidate the impact of diverse sex hormone profiles on the adaptability of muscle mass to physical training.
- Conditions
- Eumenorrhea, Intrauterine Devices, Medicated, Hormonal Contraception
- Trial name
- NCT07115849
- Testing
- Physical training
- Where
- Denmark
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- University of Aarhus
Contraception
Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods
This is a randomized, multi-center, parallel-group Phase I study to evaluate the pharmacodynamics (PD) of Medroxyprogesterone Acetate (MPA) after a single subcutaneous (SC) injection of 150 mg/mL or 300 mg/2 mL Depo-Provera CI in…
- Trial name
- NCT02456584
- Testing
- DMPA 150, DMPA 300, DMPA 104
- Where
- 2 sites in United States, Dominican Republic
- Volunteers
- 42 people, healthy volunteers welcome
- Sponsor
- FHI 360
IUCD Complication
Vaginal Misoprostol and Dinoprostone and Isonicotinic Acid Hydrazide Prior to Copper Intrauterine Device Insertion
To compare the effect of vaginal dinoprostone versus vaginal misoprostol and Isonicotinic Acid Hydrazide administered before the copper intrauterine device(IUD) insertion in reducing IUD inertion pain and the difficulty in…
- Trial name
- NCT04505943
- Testing
- Isonicotinic Acid Hydrazide, dinoprostine, misoprostol
- Where
- Egypt
- Volunteers
- 200 people
- Sponsor
- Aswan University Hospital
IUD Insertion Pain
Vaginal Dinoprostone Administration Prior to Intrauterine Device Insertion
To investigate whether vaginal dinoprostone administered before the levonorgestrel-releasing intrauterine system(IUs) insertion reduces IUD insertion pain and difficulty in insertion in adolescents and young women.
- Trial name
- NCT04079140
- Testing
- Dinoprostone
- Where
- Egypt
- Volunteers
- 130 people
- Sponsor
- Cairo University
Intra-uterine Device Complication
Efficacy and Safety of Different Doses of Vaginal Misoprostol Prior to Intra Uterine Contraceptive Device Insertion
investigators aim through this study to evaluate and compare the Safety and efficacy of different doses of misoprostol prior to IUCD insertion among women with nulliparous cervix beside the rate of occurrence of adverse effects.
- Trial name
- NCT04273984
- Testing
- Misoprostol
- Where
- 2 sites in Egypt
- Volunteers
- 180 people
- Sponsor
- Ain Shams University
HIV
Comparison of Two Intrauterine Devices (IUDs) Among Cape Town HIV-positive Women
This study will inform international medical guidelines as to whether the Levonorgestrel intrauterine device (LNG IUD), a highly effective long-acting reversible contraceptive method, is safe and acceptable as compared to the…
- Trial name
- NCT01721798
- Testing
- Mirena levonorgestrel IUD, Copper T-380a IUD
- Where
- South Africa
- Volunteers
- 199 people, healthy volunteers welcome
- Sponsor
- FHI 360
Mechanical Complication of Intrauterine Device
Immediate Post-placental Insertion of IUCD During Cesarean Delivery Versus 6 Week Post-Cesarean Insertion
The aim of current study is to compare the rates of IUCD expulsion and complications in immediate post-placental insertion versus delayed IUCD insertion (6-weeks after cesarean delivery)
- Trial name
- NCT03404622
- Testing
- IUCD
- Where
- Egypt
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- ALshaimaa Aboalhassan Ali
Pain
Lidocaine 10% Spray Reduces Pain During Intrauterine Device Insertion
Pain during intrauterine device (IUD) insertion can be a barrier to initiation. Misoprostol and nonsteroidal drugs have found to be ineffective by clinical trials.Investigators tested whether intracervical 2% lidocaine gel…
- Trial name
- NCT02020551
- Testing
- Lidocaine Spray
- Where
- Turkey (Türkiye)
- Volunteers
- 223 people, healthy volunteers welcome
- Sponsor
- Kayseri Education and Research Hospital
Acceptance Processes
Evaluation of the Impact of an Oral and Practical Presentation of Intrauterine Devices by a Health Professional on Women's Opinion as a Possible Contraceptive Method
Contraception among women in France has evolved considerably and has become a frequent reason for consultation in general practice in view of the growing shortage of gynaecologists practising in towns.
- Trial name
- EPODIU (NCT05317715)
- Testing
- Group A, who will complete a questionnaire before receiving information about intrauterine devices, Group B who will answer a questionnaire after having the information about the intrauterine devices
- Where
- France
- Volunteers
- 160 people
- Sponsor
- Raincy Montfermeil Hospital Group
Contraception
Immediate Post-placental Insertion of the Copper T 380A After Cesarean Delivery Versus 6 Week Post-cesarean Insertion
The purpose of this study is to determine, in a pilot setting, if this study is feasible in terms of recruitment, willingness to be randomized, provision of contraceptive methods, and follow-up.
- Trial name
- NCT01293760
- Testing
- Immediate insertion, 6 weeks interval insertion
- Where
- Uganda
- Volunteers
- 68 people, healthy volunteers welcome
- Sponsor
- Planned Parenthood League of Massachusetts
Contraception
Oral Ketorolac for Pain Relief During IUD Insertion
Ketorolac is a non-steroidal anti-inflammatory drug (NSAID), similar to ibuprofen but it is used to treat more severe pain. Ketorolac (Trade name: Toradol) is typically used after surgical procedures.
- Trial name
- NCT03031795
- Testing
- Ketorolac
- Volunteers
- 71 people, healthy volunteers welcome
- Sponsor
- OhioHealth
Contraception
Evaluation of a Novel Technique for Intrauterine Contraceptive Devices Insertion
The intrauterine devices are a safe, reliable, long-acting and reversible contraceptive method. It is also sound safe and cheap contraceptive methods available and is nearly maintenance free for up to 10 years.
- Trial name
- NCT02842177
- Testing
- Classic group, Uterine sounding sparing group, Transvaginal ultrasound
- Where
- Egypt
- Volunteers
- 92 people
- Sponsor
- Assiut University